IVD Contract Manufacturing Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. IVD Contract Manufacturing Market

IVD Contract Manufacturing Market Size by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 8700 Jun, 2023, by marketsandmarkets.com

The global size of IVD contract manufacturing market in terms of revenue was estimated to be worth USD 15.4 billion in 2023 and is poised to reach USD 26.7 billion by 2028, growing at a CAGR of 11.5% from 2023 to 2028. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Growth in this market can primarily be attributed to the growing need for less costly and better equipments, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations. However, the rising shortage of skilled labour, risk of patent infringement, and other Intellectual property safety failures, create a barrier to the growth of the market.

Attractive Opportunities in IVD Contract Manufacturing Market

IVD Contract Manufacturing Market

To know about the assumptions considered for the study, Request for Free Sample Report

IVD Contract Manufacturing Market

IVD Contract Manufacturing Market Dynamics

Driver: Growth in the IVD devices market in developing countries

In the coming years, China and India are expected to drive growth in the Asia Pacific region. Over 100% GDP growth is anticipated in China and India between 2020 and 2040. Emerging economies may benefit from the growth. In order to take advantage of the numerous opportunities and set up businesses in the Asia Pacific region, foreign investment will also rise in this region. Additionally, the region will use IVD devices more frequently as a result of the rising number of diagnostic public-private partnerships and government grants, which will spur a rise in contract manufacturing.

Restraint: Protecting IP is a key challenge in contract manufacturing

Protecting IP is a key challenge in contract manufacturing, as OEMs need to ensure that their proprietary information and technology are not shared with competitors or third parties. When a brand outsources its production to a third-party manufacturer, it exposes itsintellectual property(IP) to the risk of theft or infringement. It is particularly true for products that rely heavily on patented or proprietary technology or processes. This creates a glitch in obtaining contracts from mid to large scale manufcturers.

Opportunity: Increasing healthcare expenditure, infrastructure, and awareness in developing countries

China, India, and other emerging economies offer significant growth opportunities for companies operating in the medical device contract manufacturing market. China and India have laxer regulatory standards than other developing nations. One of the main factors influencing the demand for IVD devices in emerging nations is the rising prevalence of various chronic and infectious diseases, together with the rising cost of healthcare. Another important driver is the rising desire for home healthcare. Due to this, numerous manufacturers have established operations in these nations.

Challenge: Lack of constant innovation to balance technological capabilities against costs and budgertory cuts observed by end users

For firms to compete in a complicated industry like IVD, ongoing innovation is essential. These developments aid contract manufacturers by accelerating the process, lowering the margin of error, and luring clients. In recent years, CMOs have developed a number of significant capabilities, including automated manufacturing, automated labs, and automated processes. All of this, however, has a price. CMOs have substantial difficulties managing the need for cutting-edge technologies while juggling intense financial pressures.

Additionally, the budgetary cuts are observed in end users in the European region, mainly due to the economic slowdown in the past few years. Owing to such budget cuts, many end users cannot afford costly medical devices and prefer lower-priced alternatives (such as refurbished devices) or undertake the upgradation of existing medical equipment and devices. This inturn reduces the contract lots quantity obtained by the CMOs from IVD brands.

IVD Contract Manufacturing Market Ecosystem

Leading players in this market include well-established and financially stable manufacturers of IVD devices & consumables and service providers. These companies have been operating in the market for several years and possess a diversified product portfolio, advanced technologies, and strong global presence. Prominent companies in this market include Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), West Pharmaceutical Services, Inc.(US), and Thermofisher (US).

IVD Contract Manufacturing Market Ecosystem

The IVD consumables segment of IVD contract manufacturing industry is expected to register the highest CAGR during the forecast period.

Based on device type, the IVD contract manufacturing market is segmented into IVD consumables and IVD equipments. In 2022, the IVD consumables segment is expected to register the highest CAGR during the forecast period. Numerous advantages like cost savings, reduced risk, reduced period length to market the product post production, increased speed of development, and acceesibility to new technologies. CMOs can provide greater flexibility in terms of production volume, batch size, and product mix. This can be helpful for companies that are developing new products or that have fluctuating demand. For example, a CMO may be able to produce small batches of a new product to test the market, or they may be able to increase production volume to meet demand for an existing product.

The immunoassay segment of the IVD contract manufacturing industry, acquired the largest share in the technology market.

Based on technology, the IVD contract manufacturing market is segmented into immunoassay, clinical chemistry, molecular diagnostics, microbiology, hematology, and coagulation & hemosatsis. . The imunoassay segment is acquired the largest share in the market followed by the clinical chemistry segment. The adoption of enzyme linked immunoassay rapid tests has increased due to their ability to provide testing in remote areas or emergencies where no sophisticated or advanced technology is available for disease screening. This supports the market growth.

The assay development segment of the IVD contract manufacturing industry is expected to grow at the highest CAGR during the forecast period.

Based on the service type, the IVD contract manufacturing market is segmented into manufacturing services, assay development services, and other services like maintenance services, testing services, distributorship services, and post sales customer support services. The assay development services segment is expected to grow at the highest CAGR during the forecast period. Large number of contract manufacturers providing assay services for numerous analyzers and consumables developed by the OEMs and the enormous rise in new and efficient tests for immunoassays, molecular diagnostic tests, clinical chemistry testing, etc. are factors that influence the growth of the market.

APAC is estimated to be the fastest-growing region of the IVD contract manufacturing industry.

The global IVD contract manufacturing market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, APAC is estimated to be the fastest-growing regional market for IVD. The high growth in this market can majorly be attributed to the increased government initiatives to boost the outsourcing capabilities of small-scale outsourced players, the low raw material to finished goods production costs, and cheap labour is obtained in this region.

IVD Contract Manufacturing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The IVD contract manufacturing market is dominated by a few globally established players such as Jabil Inc. (US), Sanmina Corporation (US), TE Connectivity (Switzerland), Celestica Inc.(Canada), Savyon Diagnostics (Israel), West Pharmaceutical Services, Inc.(US), and Thermofisher (US). Major players adopt growth strategies to expand their geographical presence and garner higher shares in the global market, such as product launches and approvals, expansions, collaborations, and acquisitions.

Scope of the IVD Contract Manufacturing Industry

Report Metric 

Details 

Market Revenue in 2023

USD 15.0 billion

Projected Revenue by 2028

USD 25.5 billion

Revenue Rate

Poised to Grow at a CAGR of 11.2%

Market Driver

Growth in the IVD devices market in developing countries

Market Opportunity

Increasing healthcare expenditure, infrastructure, and awareness in developing countries

The study categorizes the IVD Contract Manufacturing Market to forecast revenue and analyze trends in each of the following submarkets:

By Device Type

  • IVD Equipment
  • IVD Consumables

By Technology

  • Immunoassay
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation & Hemostasis
  • Others

By Service Type

  • Manufacturing Services
  • Assay Development Services
  • Other Services

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments of IVD Contract Manufacturing Industry

  • In November 2022, Jabil Inc., expanded its developmental capabilities by opening a design center in Wrolaw, Poland. This would allow the company to develop leading-edge technologies for multiple industries including the automotive and healthcare sectors.
  • In September 2021, TE connectivity acquired Toolbox Medical Innovations (US), Wi Inc. (US), and microLIQUID(Spain). The entities leverage design and manufacturing capabilities in the United States and Europe and are focused on serving a global client base ranging from startups to multinationals in the life science, IVD and cell therapy markets.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 27)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 IVD CONTRACT MANUFACTURING MARKET SEGMENTATION
                    FIGURE 2 IVD CONTRACT MANUFACTURING INDUSTRY: REGIONAL SEGMENTATION
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
                    TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
    1.4 LIMITATIONS 
    1.5 STAKEHOLDERS 
 
2 RESEARCH METHODOLOGY (Page No. - 31)
    2.1 RESEARCH DATA 
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END-USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: JABIL INC.
          FIGURE 10 SUPPLY-SIDE ANALYSIS: MARKET (2022)
          FIGURE 11 DEMAND-SIDE ESTIMATION FOR MARKET
          FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
          FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION 
    2.5 STUDY ASSUMPTIONS 
    2.6 LIMITATIONS & RISK ASSESSMENT 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
           2.6.3 RISK ASSESSMENT
                    TABLE 2 RISK ASSESSMENT: MARKET
    2.7 RECESSION IMPACT ANALYSIS 
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 15 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 16 IVD CONTRACT MANUFACTURING INDUSTRY, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 17 MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    FIGURE 18 MARKET: GEOGRAPHICAL SNAPSHOT, 2022
 
4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 MARKET OVERVIEW 
          FIGURE 19 TECHNOLOGICAL ADVANCEMENTS IN IVD TO DRIVE MARKET
    4.2 IVD CONTRACT MANUFACTURING INDUSTRY: DEVELOPED VS. DEVELOPING MARKETS 
          FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING 
          FORECAST PERIOD 52
    4.4 MARKET: REGIONAL MIX 
          FIGURE 22 ASIA PACIFIC TO DOMINATE MARKET IN 2028
 
5 MARKET OVERVIEW (Page No. - 54)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 23 MARKET DYNAMICS: IVD CONTRACT MANUFACTURING MARKET
          TABLE 3 MARKET DYNAMICS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Growing outsourcing activity by IVD manufacturers
                    5.2.1.2 High cost of in-house IVD manufacturing
           5.2.2 RESTRAINTS
                    5.2.2.1 IP protection concerns and possibility of theft
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential of emerging economies
                                FIGURE 24 ASIA PACIFIC: HEALTHCARE EXPENDITURE, 2010–2020 (% OF GDP)
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of skilled labor
    5.3 INDUSTRY TRENDS 
           5.3.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
           5.3.2 MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING
    5.4 PORTER’S FIVE FORCES ANALYSIS 
          FIGURE 25 IVD CONTRACT MANUFACTURING INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
          TABLE 4 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.4.1 THREAT OF SUBSTITUTES
           5.4.2 BARGAINING POWER OF SUPPLIERS
           5.4.3 INTENSITY OF COMPETITIVE RIVALRY
           5.4.4 BARGAINING POWER OF BUYERS
           5.4.5 THREAT OF NEW ENTRANTS
    5.5 TARIFF AND REGULATORY LANDSCAPE 
           5.5.1 REGULATORY ANALYSIS
                    5.5.1.1 North America
                               5.5.1.1.1 US
                                              TABLE 5 US: CLASSIFICATION OF MEDICAL EQUIPMENT
                                              TABLE 6 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.5.1.1.2 Canada
                                              TABLE 7 CANADA: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                    5.5.1.2 Europe
                                TABLE 8 EUROPE: RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                                FIGURE 26 EUROPE: IVDR TIMELINE
                    5.5.1.3 Asia Pacific
                               5.5.1.3.1 Japan
                                              FIGURE 27 REGULATORY PROCESS FOR IVD DEVICES IN JAPAN
                                              TABLE 9 JAPAN: CLASSIFICATION OF IVD REAGENTS IN JAPAN
                                              TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.5.1.3.2 China
                                              TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
                               5.5.1.3.3 India
                                              FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES
                    5.5.1.4 South Korea
                                TABLE 12 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
           5.5.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.6 KEY CONFERENCES AND EVENTS IN 2022–2023 
          TABLE 18 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 
    5.7 PATENT ANALYSIS 
           5.7.1 PATENT PUBLICATION TRENDS FOR IVD DEVICES
                    FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2013–JULY 2023)
           5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD DEVICES PATENTS (JANUARY 2013–JULY 2023)
                    FIGURE 31 TOP 10 APPLICANT COUNTRIES/REGIONS FOR IVD DEVICES PATENTS (JANUARY 2013–JULY 2023)
           5.7.3 PATENT PUBLICATION TRENDS FOR IVD DEVICES
                    TABLE 19 IVD DEVICES: LIST OF MAJOR PATENTS
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 KEY TECHNOLOGIES: MARKET
           5.8.2 ADJACENT TECHNOLOGIES
    5.9 SUPPLY CHAIN ANALYSIS 
           FIGURE 32 MARKET: SUPPLY CHAIN (2022)
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF IVD PRODUCTS
           5.10.2 BUYING CRITERIA
                     FIGURE 34 KEY BUYING CRITERIA FOR IVD PRODUCTS
                     TABLE 20 KEY BUYING CRITERIA FOR IVD PRODUCTS
    5.11 ECOSYSTEM ANALYSIS 
           FIGURE 35 MARKET: ECOSYSTEM ANALYSIS (2022)
    5.12 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS 
           FIGURE 36 REVENUE SOURCES TO SHIFT TOWARD TECHNOLOGY-BASED SOLUTIONS
    5.13 MARKET: RECESSION IMPACT 
 
6 IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE (Page No. - 80)
    6.1 INTRODUCTION 
          TABLE 21 IVD CONTRACT MANUFACTURING INDUSTRY, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
    6.2 CONSUMABLES 
           6.2.1 CONSUMABLES TO DOMINATE MARKET
                    TABLE 22 MARKET FOR CONSUMABLES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 EQUIPMENT 
           6.3.1 AUTOMATION, ADVANCEMENTS, AND EMPHASIS ON EFFICIENT DIAGNOSTICS TO DRIVE MARKET
                    TABLE 23 MARKET FOR EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 IVD CONTRACT MANUFACTURING MARKET, BY TECHNOLOGY (Page No. - 84)
    7.1 INTRODUCTION 
          TABLE 24 IVD CONTRACT MANUFACTURING INDUSTRY, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    7.2 IMMUNOASSAYS 
    7.3 RISING PREVALENCE OF CANCER TO DRIVE GROWTH 
          TABLE 25 MARKET FOR IMMUNOASSAYS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 CLINICAL CHEMISTRY 
           7.4.1 GROWING INCIDENCE OF LIFESTYLE DISEASES TO DRIVE DEMAND FOR CLINICAL CHEMISTRY ASSAY TESTING
                    TABLE 26 MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 MOLECULAR DIAGNOSTICS 
           7.5.1 TECHNOLOGICAL INNOVATION IN PCR TESTING TO BOOST GROWTH
                    TABLE 27 MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.6 HEMATOLOGY 
           7.6.1 RISING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET
                    TABLE 28 MARKET FOR HEMATOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.7 MICROBIOLOGY 
           7.7.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO DRIVE MARKET
                    TABLE 29 MARKET FOR MICROBIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.8 COAGULATION & HEMOSTASIS 
           7.8.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET
                    TABLE 30 MARKET FOR COAGULATION & HEMOSTASIS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.9 OTHER TECHNOLOGIES 
          TABLE 31 MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 IVD CONTRACT MANUFACTURING MARKET, BY SERVICE TYPE (Page No. - 93)
    8.1 INTRODUCTION 
          TABLE 32 IVD CONTRACT MANUFACTURING INDUSTRY, BY SERVICE TYPE, 2021–2028 (USD MILLION)
    8.2 MANUFACTURING SERVICES 
           8.2.1 MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028
                    TABLE 33 MANUFACTURING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 ASSAY DEVELOPMENT 
           8.3.1 LOW-COST SETUP, EFFICIENCY, AND HIGH THROUGHPUT TO DRIVE DEMAND FOR ASSAY DEVELOPMENT
                    TABLE 34 ASSAY DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 OTHER SERVICES 
          TABLE 35 OTHER SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 IVD CONTRACT MANUFACTURING MARKET, BY REGION (Page No. - 99)
    9.1 INTRODUCTION 
          FIGURE 37 IVD CONTRACT MANUFACTURING INDUSTRY: GEOGRAPHIC GROWTH OPPORTUNITIES
          TABLE 36 MARKET, BY REGION, 2021–2028 (USD MILLION)
    9.2 ASIA PACIFIC 
           9.2.1 ASIA PACIFIC: RECESSION IMPACT
                    FIGURE 38 ASIA PACIFIC: MARKET SNAPSHOT
                    TABLE 37 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 38 ASIA PACIFIC: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 39 ASIA PACIFIC: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.2 CHINA
                    9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive market
                                TABLE 41 CHINA: KEY MACROINDICATORS
                                TABLE 42 CHINA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 43 CHINA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 44 CHINA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.3 JAPAN
                    9.2.3.1 Universal healthcare reimbursement policies to propel market
                                TABLE 45 JAPAN: KEY MACROINDICATORS
                                TABLE 46 JAPAN: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 47 JAPAN: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 48 JAPAN: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.4 INDIA
                    9.2.4.1 Rising contract manufacturing capabilities to support growth
                                TABLE 49 INDIA: KEY MACROINDICATORS
                                TABLE 50 INDIA: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 51 INDIA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 52 INDIA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.5 AUSTRALIA
                    9.2.5.1 Need for advanced medical and diagnostic tools to fuel growth
                                TABLE 53 AUSTRALIA: KEY MACROINDICATORS
                                TABLE 54 AUSTRALIA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 55 AUSTRALIA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 56 AUSTRALIA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.6 SOUTH KOREA
                    9.2.6.1 Rising spending on innovative IVD technologies to support market growth
                                TABLE 57 SOUTH KOREA: KEY MACROINDICATORS
                                TABLE 58 SOUTH KOREA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 59 SOUTH KOREA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 60 SOUTH KOREA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.2.7 REST OF ASIA PACIFIC
                    TABLE 61 REST OF ASIA PACIFIC: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 62 REST OF ASIA PACIFIC: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 63 REST OF ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.3 NORTH AMERICA 
           9.3.1 NORTH AMERICA: RECESSION IMPACT
                    TABLE 64 NORTH AMERICA: IVD CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 65 NORTH AMERICA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 66 NORTH AMERICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 67 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.3.2 US
                    9.3.2.1 Increasing in-house manufacturing costs to encourage shift to contract manufacturing
                                TABLE 68 US: KEY MACROINDICATORS
                                TABLE 69 US: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 70 US: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 71 US: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.3.3 CANADA
                    9.3.3.1 Strong presence of key contract manufacturing companies to drive market
                                TABLE 72 CANADA: KEY MACROINDICATORS
                                TABLE 73 CANADA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 74 CANADA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 75 CANADA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.4 EUROPE 
           9.4.1 EUROPE: RECESSION IMPACT
                    TABLE 76 EUROPE: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 77 EUROPE: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 78 EUROPE: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 79 EUROPE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.2 GERMANY
                    9.4.2.1 Germany to hold largest market share
                                TABLE 80 GERMANY: KEY MACROINDICATORS
                                TABLE 81 GERMANY: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 82 GERMANY: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 83 GERMANY: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.3 FRANCE
                    9.4.3.1 Increasing government pressure to reduce healthcare costs and budgetary constraints
                                TABLE 84 FRANCE: KEY MACROINDICATORS
                                TABLE 85 FRANCE: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 86 FRANCE: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 87 FRANCE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.4 UK
                    9.4.4.1 Risng adoption of genome-based testing and increasing accessibility of IVD
                                TABLE 88 UK: KEY MACROINDICATORS
                                TABLE 89 UK: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 90 UK: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 91 UK: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.5 ITALY
                    9.4.5.1 Rising incidence of chronic illnesses to drive market
                                TABLE 92 ITALY: KEY MACROINDICATORS
                                TABLE 93 ITALY: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 94 ITALY: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 95 ITALY: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.6 SPAIN
                    9.4.6.1 Increasing adoption of home-use medical devices to drive market
                                TABLE 96 SPAIN: KEY MACROINDICATORS
                                TABLE 97 SPAIN: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 98 SPAIN: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 99 SPAIN: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.4.7 REST OF EUROPE
                    TABLE 100 REST OF EUROPE: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 101 REST OF EUROPE: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 102 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 LATIN AMERICA: RECESSION IMPACT
                    TABLE 103 LATIN AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 104 LATIN AMERICA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 105 LATIN AMERICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 106 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Mexico to hold largest share of Latin American market
                                TABLE 107 MEXICO: KEY MACROINDICATORS
                                TABLE 108 MEXICO: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 109 MEXICO: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 110 MEXICO: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.5.3 BRAZIL
                    9.5.3.1 Favorable government initiatives and willingness to pay for better healthcare to drive market
                                TABLE 111 BRAZIL: KEY MACROINDICATORS
                                TABLE 112 BRAZIL: IVD CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                                TABLE 113 BRAZIL: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                                TABLE 114 BRAZIL: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
           9.5.4 REST OF LATIN AMERICA
                    TABLE 115 REST OF LATIN AMERICA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 116 REST OF LATIN AMERICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 117 REST OF LATIN AMERICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 GROWING HEALTHCARE INVESTMENTS AND INFRASTRUCTURAL IMPROVEMENTS TO DRIVE MARKET
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
                    TABLE 118 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT TYPE, 2021–2028 (USD MILLION)
                    TABLE 119 MIDDLE EAST & AFRICA: MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION)
                    TABLE 120 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 147)
     10.1 OVERVIEW 
     10.2 KEY STRATEGIES ADOPTED BY PLAYERS 
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 39 TOP MARKET PLAYERS DOMINATE IVD CONTRACT MANUFACTURING MARKET
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 40 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
     10.5 COMPANY EVALUATION MATRIX, 2022 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 41 MARKET: COMPANY EVALUATION QUADRANT (2022)
     10.6 COMPETITIVE BENCHMARKING 
             TABLE 121 OVERALL COMPANY FOOTPRINT
             TABLE 122 OMPANY FOOTPRINT ANALYSIS, BY PRODUCT TYPE
             TABLE 123 COMPANY FOOTPRINT ANALYSIS, BY SERVICE TYPE
             TABLE 124 COMPANY FOOTPRINT ANALYSIS, BY REGION
     10.7 COMPETITIVE SCENARIO 
             10.7.1 PRODUCT LAUNCHES
                        TABLE 125 PRODUCT LAUNCHES (JANUARY 2020–MAY 2023)
             10.7.2 DEALS
                        TABLE 126 DEALS (JANUARY 2020–MAY 2023)
             10.7.3 OTHER DEVELOPMENTS
                        TABLE 127 OTHER DEVELOPMENTS (JANUARY 2020–MAY 2023)

11 COMPANY PROFILES (Page No. - 159)
     11.1 KEY PLAYERS 
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             11.1.1 JABIL INC.
                        TABLE 128 JABIL INC.: COMPANY OVERVIEW
                        FIGURE 42 JABIL INC.: COMPANY SNAPSHOT (2022)
             11.1.2 SANMINA CORPORATION
                        TABLE 129 SANMINA CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 SANMINA CORPORATION: COMPANY SNAPSHOT (2022)
             11.1.3 TE CONNECTIVITY
                        TABLE 130 TE CONNECTIVITY: COMPANY OVERVIEW
                        FIGURE 44 TE CONNECTIVITY: COMPANY SNAPSHOT (2022)
             11.1.4 CELESTICA, INC.
                        TABLE 131 CELESTICA, INC.: COMPANY OVERVIEW
                        FIGURE 45 CELESTICA, INC.: COMPANY SNAPSHOT (2022)
             11.1.5 WEST PHARMACEUTICAL SERVICES, INC.
                        TABLE 132 WEST PHARMACEUTICALS SERVICES, INC.: COMPANY OVERVIEW
                        FIGURE 46 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
             11.1.6 SAVYON DIAGNOSTICS, LTD.
                        TABLE 133 SAVYON DIAGNOSTICS, LTD.: COMPANY OVERVIEW
             11.1.7 KMC SYSTEMS
                        TABLE 134 KMC SYSTEMS: COMPANY OVERVIEW
                        FIGURE 47 ELBIT SYSTEMS: COMPANY SNAPSHOT (2022)
             11.1.8 CENOGENICS CORPORATION
                        TABLE 135 CENOGENICS CORPORATION: COMPANY OVERVIEW
             11.1.9 NOVA BIOMEDICAL
                        TABLE 136 NOVA BIOMEDICAL: COMPANY OVERVIEW
             11.1.10 CONE BIOPRODUCTS
                        TABLE 137 CORE BIOPRODUCTS: COMPANY OVERVIEW
             11.1.11 INVETECH
                        TABLE 138 INVETECH: COMPANY OVERVIEW
                        FIGURE 48 FORTIVE: COMPANY SNAPSHOT (2022)
             11.1.12 AVIOQ, INC.
                        TABLE 139 AVIOQ, INC.: COMPANY OVERVIEW
             11.1.13 MERIDIAN BIOSCIENCE, INC.
                        TABLE 140 MERIDIAN BIOSCIENCE, INC.: COMPANY OVERVIEW
                        FIGURE 49 MERIDIAN BIOSCIENCE, INC.: COMPANY SNAPSHOT (2022)
             11.1.14 KIMBALL ELECTRONICS, INC.
                        TABLE 141 KIMBALL ELECTRONICS, INC.: COMPANY OVERVIEW
                        FIGURE 50 KIMBALL ELECTRONICS, INC.: COMPANY SNAPSHOT (2022)
             11.1.15 NEMERA
                        TABLE 142 NEMERA: COMPANY OVERVIEW
             11.1.16 VIANT MEDICAL HOLDINGS, INC.
                        TABLE 143 VIANT MEDICAL HOLDINGS, INC.: COMPANY OVERVIEW
             11.1.17 PHILLIPS-MEDISIZE CORPORATION
                        TABLE 144 PHILLIPS-MEDISIZE CORPORATION: COMPANY OVERVIEW
             11.1.18 NOLATO GW, INC.
                        TABLE 145 NOLATO GW, INC.: COMPANY OVERVIEW
                        FIGURE 51 NOLATO GW, INC.: COMPANY SNAPSHOT (2022)
             11.1.19 STRATEC SE
                        TABLE 146 STRATEC SE: COMPANY OVERVIEW
                        FIGURE 52 STRATEC SE: COMPANY SNAPSHOT (2022)
             11.1.20 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 147 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
                        FIGURE 53 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             11.1.21 FUJIREBIO
                        TABLE 148 FUJIREBIO: COMPANY OVERVIEW
                        FIGURE 54 H.U. GROUP: COMPANY SNAPSHOT (2022)
             11.1.22 BIOKIT (WERFEN)
                        TABLE 149 BIOKIT: COMPANY OVERVIEW
                        FIGURE 55 WERFEN: COMPANY SNAPSHOT (2022)
     11.2 OTHER COMPANIES 
             11.2.1 AFFINITY LIFESCIENCE
             11.2.2 SEKISUI
             11.2.3 PRESTIGE DIAGNOSTICS
 
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 210)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the usage of comprehensive secondary sources; directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the IVD Contract Manufacturing Industry. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends to the bottommost level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Extensive primary research was conducted after obtaining information regarding the IVD Contract Manufacturing Market scenario through secondary research. Several primary interviews were conducted with market experts from both, the demand and supply sides across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Primary data was collected through questionnaires, emails, and telephonic interview. The primary sources included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors, from business development, marketing, product development/innovation teams, and related key executives from IVD contract manufacturer; system integrators; component providers; distributors; and key opinion leaders/consultants.

Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. The primary sources from the supply side and demand side are detailed below.

A breakdown of the primary respondents is provided below:

Breakdown Of Primary Interviews: Supply-Side Participants, By Company Type, Designation, And Region

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

Breakdown of Primary Interviews: By Company Type, Designation, and Region

IVD Contract Manufacturing Market Size, and Share

Note: Others include department heads and research scientists

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the IVD Contract Manufacturing Industry was arrived at after data triangulation from two different approaches, as mentioned below. After each approach, the weighted average of all approaches was taken based on the level of assumptions used in each approach.

Global IVD Contract Manufacturing Market Size: Bottom-Up Approach

IVD Contract Manufacturing Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global IVD Contract Manufacturing Market Size: Top-Down Approach

IVD Contract Manufacturing Market Size, and Share

Data Triangulation

After arriving at the market size, the total market was divided into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and sub-segments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Market Definition

IVD contract manufacturing is a process wherein a manufacturing company makes IVD equipment or consumables that can be sold later by other companies. IVD contract manufacturers specialize in a certain process or task and offer expertise due to their frequent practice of manufacturing. These companies  may also offer assay development, maintenance services, testing services, and distribution services to Original Equipment Manufacturers or Small and Mid-Size organizations.

Key Stakeholders

  • Original Equipment Manufacturers
  • Suppliers and distributors of IVD equipment 
  • Small and Mid-size IVD manufactures
  • Government bodies/municipal corporations
  • Venture capitalists
  • US Food and Drug Administration (US FDA)
  • European Union (EU)

Objectives of the Study

  • To describe, analyze, and forecast the IVD Contract Manufacturing Market, by device type, service type, technology, and region.
  • To describe and forecast the IVD Contract Manufacturing Industry for key regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the IVD Contract Manufacturing Industry 
  • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players.
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the IVD Contract Manufacturing Industry.
  • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the IVD Contract Manufacturing Market

Available customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the RoE IVD Contract Manufacturing Industry into Austria, Finland, and others
  • Further breakdown of the RoLATAM IVD Contract Manufacturing Industry into Argentina, Colombia, Chile, and others

Competitive Landscape Assessment

Market share analysis for the North America and Europe region, which provides market shares of the top 3–5 key players in the IVD Contract Manufacturing Industry

  • Competitive leadership mapping for established players in the US
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
MD 8700
Published ON
Jun, 2023
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the IVD Contract Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback